Menu Search
Equities

China Resources Medical Holdings Company Ltd

1PH:STU

China Resources Medical Holdings Company Ltd

Actions
  • Price (EUR)0.51
  • Today's Change0.01 / 2.00%
  • Shares traded0.00
  • 1 Year change-35.03%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and external customers. The General Healthcare Services segment provides hospital services provided through Jian Gong Hospital and 999 Medical Clinic (Shenzhen) Co., Ltd. The Hospital Management and Consulting Services segment provides comprehensive management and consulting services to IOT Hospitals and sponsored hospitals and receives an annual fee. The Other Hospital-Derived Services segment provides medical consultation service to third parties.

  • Revenue in HKD (TTM)10.92bn
  • Net income in HKD278.50m
  • Incorporated2013
  • Employees20.17k
  • Location
    China Resources Medical Holdings Company LtdE-825No. 6 Taiping Street, Xicheng DistrictBEIJING 100050ChinaCHN
  • Phone+86 1 059361058
  • Fax+86 1 059361935
  • Websitehttp://www.crmedical.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.